Correlation Between Viridian Therapeutics and BioNTech

Can any of the company-specific risk be diversified away by investing in both Viridian Therapeutics and BioNTech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viridian Therapeutics and BioNTech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Viridian Therapeutics and BioNTech SE, you can compare the effects of market volatilities on Viridian Therapeutics and BioNTech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viridian Therapeutics with a short position of BioNTech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viridian Therapeutics and BioNTech.

Diversification Opportunities for Viridian Therapeutics and BioNTech

0.24

Correlation Coefficient

Viridian Therapeutics  BioNTech

Modest diversification

The 3 months correlation between Viridian and BioNTech is 0.24. Overlapping area represents the amount of risk that can be diversified away by holding Viridian Therapeutics and BioNTech SE in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioNTech SE and Viridian Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viridian Therapeutics are associated (or correlated) with BioNTech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioNTech SE has no effect on the direction of Viridian Therapeutics i.e., Viridian Therapeutics and BioNTech go up and down completely randomly.

Pair Corralation between Viridian Therapeutics and BioNTech

Assuming the 90 days trading horizon Viridian Therapeutics is expected to under-perform the BioNTech. In addition to that, Viridian Therapeutics is 1.88 times more volatile than BioNTech SE. It trades about -0.09 of its total potential returns per unit of risk. BioNTech SE is currently generating about -0.02 per unit of volatility. If you would invest  11,781  in BioNTech SE on December 2, 2024 and sell it today you would lose (716.00) from holding BioNTech SE or give up 6.08% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Viridian Therapeutics  vs.  BioNTech SE

Viridian Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Viridian Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

BioNTech SE

Risk-Adjusted Performance

Very Weak

Over the last 90 days BioNTech SE has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent essential indicators, BioNTech is not utilizing all of its potentials. The newest stock price mess, may contribute to short-term losses for the institutional investors.

Pair Trading with Viridian Therapeutics and BioNTech

The main advantage of trading using opposite Viridian Therapeutics and BioNTech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viridian Therapeutics position performs unexpectedly, BioNTech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioNTech will offset losses from the drop in BioNTech's long position.

The idea behind Viridian Therapeutics and BioNTech SE pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.